The new pharmaceutical regulatory procedures for Europe

Author： Jefferys D.B.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.16, Iss.7, 1995-07, pp. : 226-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Product Pipelines and Pharmaceutical Risk Management in the New Era of Strict Regulatory Scrutiny

By Sietsema William K.  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 2, 2006-01 ,pp. : 99-106

Adis International

Access to resources Recommend Favorite

Multiple Testing Procedures in Two Pivotal Clinical Trials for Approval of a New Pharmaceutical Product

By Wiens Brian  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 669-681

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmaceutical patent litigation in Europe

By Cook T.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

Procedures for Health Risk Assessment in Europe

By Seeley M.R.   Tonner-Navarro L.E.   Beck B.D.   deskin R.   Feron V.J.   Johanson G.   Bolt H.M.  

Regulatory Toxicology and Pharmacology, Vol. 34, Iss. 2, 2001-10 ,pp. : 153-169

Academic Press

Access to resources Recommend Favorite

Other regulatory news from Europe

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite